Recurrent myoglobinuria due to carnitine plamitoyltransferase II deficiency: Clinical, biochemical, and genetic features of adult-onset cases

New Zealand Medical Journal

Volumn 118, Issue 1210, 2005, Pages

  Kilfoyle, Dean ^a   Hutchinson, David ^a   Potter, Howard ^b   George, Peter ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE II; CREATINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL FEATURE; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEFICIENCY; EXERCISE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INFECTION; MALE; MUSCLE BIOPSY; MYALGIA; MYOGLOBINURIA; ONSET AGE; RECURRENT DISEASE;

EID: 27244435657     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Penn AS. Myoglobinuria. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill;1994. p1679-96.
2. DiMauro S, Melis-DiMauro PM. Muscle carnitine palmitoyltransferase deficiency and myoglobinuria. Science. 1973;182:929-31.
3. Bonnefont JP, Demaugre F, Prip-Buss C, et al. Carnitine Palmitoyltransferase Deficiencies. Mol Genet Metab. 1999;68:424-40.
4. Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med. 1991;325:1862-4.
5. Taroni F, Verderio E, Garavaglia B, et al. Biochemical and molecular studies of carnitine palmitoyltransferase II deficiency with hepatocardiomyopathic presentation. Prog Clin Biol Res. 1992;375:521-31.
6. Engel AG. The Muscle Biopsy. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill;1994. p822-31.
7. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Biochem J. 1983;214:21-8.
8. Ciulla TA, Sklar RM, Hauser SL. A simple method for DNA purification from peripheral blood. Anal. Biochem. 1988;174:485-8.
9. Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999;13:210-20.
10. DiMauro S, Tsujino S. Nonlysosomal Glycogenoses. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill;1994. p1554-76.
11. Woeltje KF, Esser V, Weis BC, et al. Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system. J Biol Chem. 1990;265:10714-9
12. Britton CH, Mackey DW, Esser V, et al. Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B). Genomics. 1997;40:209-11.
13. Gellera C, Verderio E, Floridia, G, et al. Assignment of the human carnitine palmitoyltransferase II gene (CPT1) to chromosome 1p32. Genomics. 1994;24:195-7.
14. Zierz S. Carnitine palmitoyltransferase deficiency. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p1577-86.
15. Tonin P, Lewis P, Servidei S, DiMauro S. Metabolic causes of myoglobinuria. Ann Neurol. 1990;27:181-5.
16. Karadimas CL, Greenstein P, Sue CM, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA. Neurology. 2000;55:644-9.
17. Vissing J, Haller RG. Metabolic myopathies. In: Pourmand R, ed. Neuromuscular disease: expert clinicians views. Boston: Butterworth-Heinemann; 2001 p93-410.
18. Finocchiaro G, Taroni F, Rocchi M, et al. cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci USA. 1991;88:661-5.
19. Thuillier L, Hidayeth R, Droin V, et al. Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Mutat. 2003;21:493-501.
20. Wieser T, Deschauer M, Olek K. Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients. Neurology. 2003;60:1351-3.
21. Taroni F, Verderio E, Dworzak F, et al. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet. 1993;4:314-20.
22. Ørngreen MC, Olsen DB, Vissing J. Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose. Neurology. 2002;59:1046-51.
23. Ørngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology. 2003;61:559-61.
24. Van den Hout H, Reuser AJ, Vulto AG, et al. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356:397-8.
25. Sun BD, Chen YT, Bird A, at al. Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector. Mol Ther. 2003;7:193-201.